Newborn hepatitis B vaccination policy in hospital nurseries.

Michael D. Cabana, Kimberly D. Aiken, Sarah J. Clark

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: Hepatitis B vaccination (HBV) is unlike any other immunization series because it can be initiated in the hospital nursery. The objective of this study was to describe how hospital nurseries develop HBV policies and to describe the sources of information used for learning about national HBV recommendations. METHODS: A cross-sectional telephone survey was conducted on a national random sample of nursery medical directors of 290 hospital nurseries representing all 50 states. The outcomes measured were methods used by hospital nurseries to develop HBV policy and sources of information used by nursery directors to learn about national HBV recommendations. RESULTS: Directors at 207 (71%) of 290 eligible nurseries responded. Of the 184 nurseries that have considered developing an HBV policy, the most common method was through a formal committee (43%). In 104 (57%) of these nurseries a nurse was involved in policy development, and in 15 (8%) the nurse manager initiated the process. The most common source of initial information about the July 1999 announcement to suspend the nursery dose of HBV was the American Academy of Pediatrics. The most common initial source of information about the availability of thimerosal-free HBV was pharmaceutical companies. Physician, nurse, and pharmacist colleagues were cited as sources of information with similar frequency (12, 11, and 20 cases, respectively). CONCLUSIONS: Physicians are not the sole initiators and developers of HBV policy in the newborn nursery. Although almost all nurseries designate a physician as a nursery director, in many cases (55% of cases) the position is "rotating" or as part of another administrative position (63% of cases). Many hospital nurseries involve nurses and pharmacists in key roles to stay current with HBV recommendations and to develop subsequent policy. Using nonphysician national organizations as additional channels of information might expedite dissemination about changes in HBV recommendations and, as a result, improve nursery awareness and adoption of national HBV guidelines.

Original languageEnglish (US)
Pages (from-to)E21
JournalPediatrics
Volume109
Issue number2
StatePublished - Feb 2002
Externally publishedYes

Fingerprint

Hospital Nurseries
Hepatitis B
Nurseries
Vaccination
Newborn Infant
Nurses
Physicians
Pharmacists
Thimerosal
Physician Executives
Nurse Administrators
Policy Making

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Newborn hepatitis B vaccination policy in hospital nurseries. / Cabana, Michael D.; Aiken, Kimberly D.; Clark, Sarah J.

In: Pediatrics, Vol. 109, No. 2, 02.2002, p. E21.

Research output: Contribution to journalArticle

Cabana, MD, Aiken, KD & Clark, SJ 2002, 'Newborn hepatitis B vaccination policy in hospital nurseries.', Pediatrics, vol. 109, no. 2, pp. E21.
Cabana, Michael D. ; Aiken, Kimberly D. ; Clark, Sarah J. / Newborn hepatitis B vaccination policy in hospital nurseries. In: Pediatrics. 2002 ; Vol. 109, No. 2. pp. E21.
@article{2197aaa2326345df882449366cfeb7ac,
title = "Newborn hepatitis B vaccination policy in hospital nurseries.",
abstract = "OBJECTIVE: Hepatitis B vaccination (HBV) is unlike any other immunization series because it can be initiated in the hospital nursery. The objective of this study was to describe how hospital nurseries develop HBV policies and to describe the sources of information used for learning about national HBV recommendations. METHODS: A cross-sectional telephone survey was conducted on a national random sample of nursery medical directors of 290 hospital nurseries representing all 50 states. The outcomes measured were methods used by hospital nurseries to develop HBV policy and sources of information used by nursery directors to learn about national HBV recommendations. RESULTS: Directors at 207 (71{\%}) of 290 eligible nurseries responded. Of the 184 nurseries that have considered developing an HBV policy, the most common method was through a formal committee (43{\%}). In 104 (57{\%}) of these nurseries a nurse was involved in policy development, and in 15 (8{\%}) the nurse manager initiated the process. The most common source of initial information about the July 1999 announcement to suspend the nursery dose of HBV was the American Academy of Pediatrics. The most common initial source of information about the availability of thimerosal-free HBV was pharmaceutical companies. Physician, nurse, and pharmacist colleagues were cited as sources of information with similar frequency (12, 11, and 20 cases, respectively). CONCLUSIONS: Physicians are not the sole initiators and developers of HBV policy in the newborn nursery. Although almost all nurseries designate a physician as a nursery director, in many cases (55{\%} of cases) the position is {"}rotating{"} or as part of another administrative position (63{\%} of cases). Many hospital nurseries involve nurses and pharmacists in key roles to stay current with HBV recommendations and to develop subsequent policy. Using nonphysician national organizations as additional channels of information might expedite dissemination about changes in HBV recommendations and, as a result, improve nursery awareness and adoption of national HBV guidelines.",
author = "Cabana, {Michael D.} and Aiken, {Kimberly D.} and Clark, {Sarah J.}",
year = "2002",
month = "2",
language = "English (US)",
volume = "109",
pages = "E21",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Newborn hepatitis B vaccination policy in hospital nurseries.

AU - Cabana, Michael D.

AU - Aiken, Kimberly D.

AU - Clark, Sarah J.

PY - 2002/2

Y1 - 2002/2

N2 - OBJECTIVE: Hepatitis B vaccination (HBV) is unlike any other immunization series because it can be initiated in the hospital nursery. The objective of this study was to describe how hospital nurseries develop HBV policies and to describe the sources of information used for learning about national HBV recommendations. METHODS: A cross-sectional telephone survey was conducted on a national random sample of nursery medical directors of 290 hospital nurseries representing all 50 states. The outcomes measured were methods used by hospital nurseries to develop HBV policy and sources of information used by nursery directors to learn about national HBV recommendations. RESULTS: Directors at 207 (71%) of 290 eligible nurseries responded. Of the 184 nurseries that have considered developing an HBV policy, the most common method was through a formal committee (43%). In 104 (57%) of these nurseries a nurse was involved in policy development, and in 15 (8%) the nurse manager initiated the process. The most common source of initial information about the July 1999 announcement to suspend the nursery dose of HBV was the American Academy of Pediatrics. The most common initial source of information about the availability of thimerosal-free HBV was pharmaceutical companies. Physician, nurse, and pharmacist colleagues were cited as sources of information with similar frequency (12, 11, and 20 cases, respectively). CONCLUSIONS: Physicians are not the sole initiators and developers of HBV policy in the newborn nursery. Although almost all nurseries designate a physician as a nursery director, in many cases (55% of cases) the position is "rotating" or as part of another administrative position (63% of cases). Many hospital nurseries involve nurses and pharmacists in key roles to stay current with HBV recommendations and to develop subsequent policy. Using nonphysician national organizations as additional channels of information might expedite dissemination about changes in HBV recommendations and, as a result, improve nursery awareness and adoption of national HBV guidelines.

AB - OBJECTIVE: Hepatitis B vaccination (HBV) is unlike any other immunization series because it can be initiated in the hospital nursery. The objective of this study was to describe how hospital nurseries develop HBV policies and to describe the sources of information used for learning about national HBV recommendations. METHODS: A cross-sectional telephone survey was conducted on a national random sample of nursery medical directors of 290 hospital nurseries representing all 50 states. The outcomes measured were methods used by hospital nurseries to develop HBV policy and sources of information used by nursery directors to learn about national HBV recommendations. RESULTS: Directors at 207 (71%) of 290 eligible nurseries responded. Of the 184 nurseries that have considered developing an HBV policy, the most common method was through a formal committee (43%). In 104 (57%) of these nurseries a nurse was involved in policy development, and in 15 (8%) the nurse manager initiated the process. The most common source of initial information about the July 1999 announcement to suspend the nursery dose of HBV was the American Academy of Pediatrics. The most common initial source of information about the availability of thimerosal-free HBV was pharmaceutical companies. Physician, nurse, and pharmacist colleagues were cited as sources of information with similar frequency (12, 11, and 20 cases, respectively). CONCLUSIONS: Physicians are not the sole initiators and developers of HBV policy in the newborn nursery. Although almost all nurseries designate a physician as a nursery director, in many cases (55% of cases) the position is "rotating" or as part of another administrative position (63% of cases). Many hospital nurseries involve nurses and pharmacists in key roles to stay current with HBV recommendations and to develop subsequent policy. Using nonphysician national organizations as additional channels of information might expedite dissemination about changes in HBV recommendations and, as a result, improve nursery awareness and adoption of national HBV guidelines.

UR - http://www.scopus.com/inward/record.url?scp=0036483604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036483604&partnerID=8YFLogxK

M3 - Article

C2 - 11826231

AN - SCOPUS:0036483604

VL - 109

SP - E21

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -